{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:37:23Z","timestamp":1790289443197,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13014-017-0897-6","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:08:58Z","timestamp":1508411338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation"],"prefix":"10.1186","volume":"12","author":[{"given":"Michael C.","family":"Repka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Aghdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaan K.","family":"Kataria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Suy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Lischalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"issue":"1","key":"897_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"897_CR2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","volume":"120","author":"BK Edwards","year":"2014","unstructured":"Edwards BK, Noone A-M, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014;120(9):1290\u2013314.","journal-title":"Cancer"},{"issue":"19","key":"897_CR3","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","volume":"103","author":"WJ Curran","year":"2011","unstructured":"Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. J Natl Cancer Inst. 2011;103(19):1452\u201360.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"897_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"JD Bradley","year":"2015","unstructured":"Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187\u201399.","journal-title":"Lancet Oncol."},{"issue":"8","key":"897_CR5","first-page":"706","volume":"2","author":"P Goldstraw","year":"2007","unstructured":"Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2007;2(8):706\u201314.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer."},{"issue":"1","key":"897_CR6","first-page":"39","volume":"11","author":"P Goldstraw","year":"2016","unstructured":"Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2016;11(1):39\u201351.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer."},{"issue":"3","key":"897_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/02656736.2015.1137640","volume":"32","author":"M Cheng","year":"2016","unstructured":"Cheng M, Fay M, Steinke K. Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: a retrospective study. Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2016;32(3):316\u201323.","journal-title":"Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group"},{"issue":"1","key":"897_CR8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2013.08.014","volume":"109","author":"SA McAvoy","year":"2013","unstructured":"McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, et al. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2013;109(1):38\u201344.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"issue":"5","key":"897_CR9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ejcts\/ezv348","volume":"49","author":"T Mizobuchi","year":"2016","unstructured":"Mizobuchi T, Yamamoto N, Nakajima M, Baba M, Miyoshi K, Nakayama H, et al. Salvage surgery for local recurrence after carbon ion radiotherapy for patients with lung cancer. Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2016;49(5):1503\u20139.","journal-title":"Eur J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg"},{"issue":"4","key":"897_CR10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ijrobp.2014.07.030","volume":"90","author":"S McAvoy","year":"2014","unstructured":"McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang JY, et al. Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes. Int J Radiat Oncol Biol Phys. 2014;90(4):819\u201327.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"897_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PPO.0b013e318292e4e3","volume":"19","author":"H Willers","year":"2013","unstructured":"Willers H, Azzoli CG, Santivasi WL, Xia F. Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer. Cancer J Sudbury Mass. 2013;19(3):200\u20137.","journal-title":"Cancer J Sudbury Mass"},{"issue":"11","key":"897_CR12","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070\u20136.","journal-title":"JAMA"},{"issue":"6","key":"897_CR13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16(6):630\u20137.","journal-title":"Lancet Oncol"},{"issue":"5","key":"897_CR14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ijrobp.2009.09.070","volume":"78","author":"P Kelly","year":"2010","unstructured":"Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao Z, Komaki R, et al. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys. 2010;78(5):1387\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"897_CR15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.radonc.2013.11.017","volume":"110","author":"JM Kilburn","year":"2014","unstructured":"Kilburn JM, Kuremsky JG, Blackstock AW, Munley MT, Kearns WT, Hinson WH, et al. Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2014;110(3):505\u201310.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"9","key":"897_CR16","first-page":"1462","volume":"7","author":"N Trakul","year":"2012","unstructured":"Trakul N, Harris JP, Le Q-T, Hara WY, Maxim PG, Loo BW, et al. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2012 Sep;7(9):1462\u20135.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer."},{"key":"897_CR17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3389\/fonc.2014.00248","volume":"4","author":"D Owen","year":"2014","unstructured":"Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, et al. Safety and tolerability of SBRT after high-dose external beam radiation to the lung. Front Oncol. 2014;4:376.","journal-title":"Front Oncol"},{"issue":"2","key":"897_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/COC.0000000000000039","volume":"39","author":"J Parks","year":"2016","unstructured":"Parks J, Kloecker G, Woo S, Dunlap NE. Stereotactic body radiation therapy as salvage for Intrathoracic recurrence in patients with previously irradiated locally advanced non-small cell lung cancer. Am J Clin Oncol. 2016;39(2):147\u201353.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"897_CR19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13566-014-0175-2","volume":"4","author":"NR Patel","year":"2015","unstructured":"Patel NR, Lanciano R, Sura K, Yang J, Lamond J, Feng J, et al. Stereotactic body radiotherapy for re-irradiation of lung cancer recurrence with lower biological effective doses. J Radiat Oncol. 2015;4(1):65\u201370.","journal-title":"J Radiat Oncol"},{"key":"897_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1748-717X-8-99","volume":"8","author":"M Reyngold","year":"2013","unstructured":"Reyngold M, Wu AJ, McLane A, Zhang Z, Hsu M, Stein NF, et al. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol Lond Engl. 2013 Apr 25;8:99.","journal-title":"Radiat Oncol Lond Engl"},{"issue":"5","key":"897_CR21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ijrobp.2014.01.012","volume":"88","author":"M Trovo","year":"2014","unstructured":"Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, et al. Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;88(5):1114\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"30","key":"897_CR22","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1200\/JCO.2006.07.5937","volume":"24","author":"R Timmerman","year":"2006","unstructured":"Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(30):4833\u20139.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"7","key":"897_CR23","first-page":"1081","volume":"11","author":"H Tekatli","year":"2016","unstructured":"Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, et al. Outcomes of Hypofractionated high-dose radiotherapy in poor-risk patients with \u201cUltracentral\u201d non-small cell lung cancer. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2016;11(7):1081\u20139.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"24","key":"897_CR24","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMc1203770","volume":"366","author":"MN Corradetti","year":"2012","unstructured":"Corradetti MN, Haas AR, Rengan R. Central-airway necrosis after stereotactic body-radiation therapy. N Engl J Med. 2012;366(24):2327\u20139.","journal-title":"N Engl J Med"},{"key":"897_CR25","first-page":"109","volume":"5","author":"BS Gill","year":"2015","unstructured":"Gill BS, Clump DA, Burton SA, Christie NA, Schuchert MJ, Heron DE. Salvage stereotactic body radiotherapy for locally recurrent non-small cell lung cancer after sublobar resection and i(125) vicryl mesh brachytherapy. Front Oncol. 2015;5:109.","journal-title":"Front Oncol"},{"issue":"1","key":"897_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2014.05.011","volume":"90","author":"KL Stephans","year":"2014","unstructured":"Stephans KL, Djemil T, Diaconu C, Reddy CA, Xia P, Woody NM, et al. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity. Int J Radiat Oncol Biol Phys. 2014;90(1):197\u2013202.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"897_CR27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/cncr.20539","volume":"101","author":"H Onishi","year":"2004","unstructured":"Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101(7):1623\u201331.","journal-title":"Cancer"},{"issue":"1","key":"897_CR28","first-page":"222","volume":"98","author":"JC Ho","year":"2017","unstructured":"Ho JC, Nguyen QN, Li H, Allen PK, Zhang X, Zhu XR, et al. Reirradiation of thoracic cancers with intensity modulated proton therapy. Int J Radiat Oncol Biol Phys. 2017;98(1):222.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-017-0897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T11:09:02Z","timestamp":1508411342000},"score":1,"resource":{"primary":{"URL":"http:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-017-0897-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1186\/s13014-017-0897-6","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,19]]},"article-number":"162"}}